4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001762572-26-000002
Options or other derivatives
- Chief Patient Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hoitt Jason Chief Patient Officer | 2026-02-17 | Grant or award · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | D | ||
| Hoitt Jason Chief Patient Officer | 2026-02-17 | Grant or award · Restricted Stock Units | +48,000 | 48,000 | D | ||
Loading xslF345X05/form4-02192026_090202.xml…